BeOne Medicines
ONC
#590
Rank
HK$330.46 B
Marketcap
HK$2,905
Share price
-0.33%
Change (1 day)
18.72%
Change (1 year)
BeOne Medicines formerly known as BeiGene, is a multinational pharmaceutical company engaged in the R&D, commercialization of molecularly-targeted, and immuno-oncology drugs for the treatment of cancer.

Quarterly Reports

Thumbnail BeOne Medicines Quarterly Report 2026-q2

Quarterly Report 2026-q2

Language: English

View Quarterly Report
Thumbnail BeOne Medicines Quarterly Report 2026-q1

Quarterly Report 2026-q1

Language: English

View Quarterly Report
Thumbnail BeOne Medicines Quarterly Report 2025-q3

Quarterly Report 2025-q3

Language: English

View Quarterly Report
Thumbnail BeOne Medicines Quarterly Report 2025-q2

Quarterly Report 2025-q2

Language: English

View Quarterly Report